Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-16

Clinical Trial Update: The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes

View source ↗

Summary

A completed clinical trial investigates the relationship between plasma irisin levels and endothelial dysfunction in people with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wuhan General Hospital of Guangzhou Military Command | Conditions: Irisin, Endothelial Dysfunction | Status: COMPLETED